Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Stock Exchange of Hong Kong  >  Beigene Ltd       

BEIGENE LTD

SummaryNewsRatingsCalendarCompany 
News SummaryMost relevantAll newsOfficial PublicationsSector news

Investigation of BeiGene Announced by Holzer & Holzer, LLC

share with twitter share with LinkedIn share with facebook
share via e-mail
0
09/12/2019 | 02:21pm EDT

Holzer & Holzer, LLC is investigating whether certain statements made by BeiGene, Ltd. (“BeiGene” or the “Company”) (NASDAQ: BGNE) complied with federal securities laws. On September 5, 2019, J Capital Research published a report asserting that the Company engaged in improper sales practices “to persuade investors that it can develop a successful platform in China.” The price of BeiGene stock fell following the announcement.

If you purchased shares of BeiGene and suffered a loss on that investment, you are encouraged to contact Corey D. Holzer, Esq. at cholzer@holzerlaw.com or Luke R. Kennedy at lkennedy@holzerlaw.com, or by toll-free telephone at (888) 508-6832 to discuss your legal rights.

Holzer & Holzer, LLC is an Atlanta, Georgia law firm that dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. Since its founding in 2000, Holzer & Holzer attorneys have played critical roles in recovering hundreds of millions of dollars for shareholders victimized by fraud and other corporate misconduct. More information about the firm is available through its website, www.holzerlaw.com and upon request from the firm. Holzer & Holzer, LLC has paid for the dissemination of this promotional communication, and Corey D. Holzer is the attorney responsible for its content.


© Business Wire 2019
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on BEIGENE LTD
09/16GLANCY PRONGAY & MURRAY LLP : Continues Its Investigation on Behalf of BeiGene, ..
BU
09/16Law Offices of Howard G. Smith Continues Its Investigation on Behalf of BeiGe..
BU
09/13BRAGAR EAGEL & SQUIRE, P.C. IS INVES : BGNE) on Behalf of BeiGene Stockholders a..
BU
09/13GLANCY PRONGAY & MURRAY LLP : Announces Investigation on Behalf of BeiGene, Ltd...
BU
09/12Law Offices of Howard G. Smith Announces Investigation on Behalf of BeiGene, ..
BU
09/12INVESTIGATION REMINDER : The Schall Law Firm Announces it is Investigating Claim..
BU
09/12Investigation of BeiGene Announced by Holzer & Holzer, LLC
BU
09/12BEIGENE : Announces Clinical Data to Be Presented at the Annual Meeting of the C..
AQ
09/11INVESTIGATION ALERT : The Schall Law Firm Announces it is Investigating Claims A..
BU
09/11Rosen Law Firm Announces Investigation of Securities Claims Against BeiGene, ..
BU
More news
Chart BEIGENE LTD
Duration : Period :
Beigene Ltd Technical Analysis Chart | MarketScreener
Full-screen chart
Managers
NameTitle
John V. Oyler Chairman & Chief Executive Officer
Xiao Bin Wu President
Maggie Liu Head-Operations
Howard Liang Chief Financial & Strategy Officer
Jane E Huang Chief Medical Officer-Hematology
Sector and Competitors
1st jan.Capitalization (M$)
BEIGENE LTD8 128
GILEAD SCIENCES5.32%84 245
VERTEX PHARMACEUTICALS7.15%44 966
REGENERON PHARMACEUTICALS-23.46%30 815
GENMAB27.92%13 161
NEUROCRINE BIOSCIENCES, INC.36.96%8 829